Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AgeX Therapeutics, Inc. Common Stock (NY:AGE)

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Mar 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AgeX Therapeutics, Inc. Common Stock

< Previous 1 2 Next >
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE
From Kahn Swick & Foti, LLC
Via Business Wire
Why IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Shares of International Business Machines Corporation (NYSE: IBM) shares rose sharply in today’s pre-market trading as the company reported reported stronger-than-expected results for its fourth... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today. 
Via InvestorPlace
What's Going On With Penny Stock AgeX Therapeutics?
Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE: PFE) will license, on a non-exclusive basis, Serina's  
Via Benzinga
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE
From Kahn Swick & Foti, LLC
Via Business Wire
AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
From AgeX Therapeutics, Inc.
Via Business Wire
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday. 
Via Benzinga
Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. 
Via Benzinga
AgeX Therapeutics Announces Appeal of NYSE American Determination
From AgeX Therapeutics, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday! 
Via InvestorPlace
AgeX Therapeutics Reports First Quarter 2023 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
From AgeX Therapeutics , Inc.
Via Business Wire
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Second Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. 
Via Benzinga
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports First Quarter 2022 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
From AgeX Therapeutics, Inc.
Via Business Wire
60 Biggest Movers From Yesterday
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS